320 related articles for article (PubMed ID: 16919518)
21. Prevention of sudden cardiac death with omega-3 fatty acids in patients with coronary heart disease: a meta-analysis of randomized controlled trials.
Zhao YT; Chen Q; Sun YX; Li XB; Zhang P; Xu Y; Guo JH
Ann Med; 2009; 41(4):301-10. PubMed ID: 19148838
[TBL] [Abstract][Full Text] [Related]
22. Cardiovascular disease prevention and treatment.
von Schacky C
Prostaglandins Leukot Essent Fatty Acids; 2009; 81(2-3):193-8. PubMed ID: 19520557
[TBL] [Abstract][Full Text] [Related]
23. Long-chain omega-3 fatty acids from fish reduce sudden cardiac death in patients with coronary heart disease.
Richter WO
Eur J Med Res; 2003 Aug; 8(8):332-6. PubMed ID: 12915328
[TBL] [Abstract][Full Text] [Related]
24. Omega-3 fatty acids in the prevention-management of cardiovascular disease.
Simopoulos AP
Can J Physiol Pharmacol; 1997 Mar; 75(3):234-9. PubMed ID: 9164707
[TBL] [Abstract][Full Text] [Related]
25. Omega-3 fatty acids and cardiovascular disease.
von Schacky C
Curr Opin Clin Nutr Metab Care; 2007 Mar; 10(2):129-35. PubMed ID: 17284999
[TBL] [Abstract][Full Text] [Related]
26. Omacor and omega-3 fatty acids for treatment of coronary artery disease and the pleiotropic effects.
Kar S
Am J Ther; 2014; 21(1):56-66. PubMed ID: 21975796
[TBL] [Abstract][Full Text] [Related]
27. Red blood cell omega-3 fatty acids and the risk of ventricular arrhythmias in patients with heart failure.
Wilhelm M; Tobias R; Asskali F; Kraehner R; Kuly S; Klinghammer L; Boehles H; Daniel WG
Am Heart J; 2008 Jun; 155(6):971-7. PubMed ID: 18513506
[TBL] [Abstract][Full Text] [Related]
28. Antiarrhythmic effects of omega-3 fatty acids: from epidemiology to bedside.
De Caterina R; Madonna R; Zucchi R; La Rovere MT
Am Heart J; 2003 Sep; 146(3):420-30. PubMed ID: 12947358
[TBL] [Abstract][Full Text] [Related]
29. [Pharmacological aspects of secondary prevention post-MI].
Schrör K
Z Kardiol; 2004; 93 Suppl 1():I1-3. PubMed ID: 15021997
[TBL] [Abstract][Full Text] [Related]
30. Prescription omega-3 fatty acids and their lipid effects: physiologic mechanisms of action and clinical implications.
Bays HE; Tighe AP; Sadovsky R; Davidson MH
Expert Rev Cardiovasc Ther; 2008 Mar; 6(3):391-409. PubMed ID: 18327998
[TBL] [Abstract][Full Text] [Related]
31. A multi-country health-economic evaluation of highly concentrated n-3 polyunsaturated fatty acids in the secondary prevention after myocardial infarction.
Lamotte M; Annemans L; Kawalec P; Zoellners Y
Herz; 2006 Dec; 31 Suppl 3():74-82. PubMed ID: 17575809
[TBL] [Abstract][Full Text] [Related]
32. Cardiovascular benefits of omega-3 fatty acids.
von Schacky C; Harris WS
Cardiovasc Res; 2007 Jan; 73(2):310-5. PubMed ID: 16979604
[TBL] [Abstract][Full Text] [Related]
33. [Primary prevention of sudden cardiac death implanted cardioverter defibrillator (ICD) versus antiarrhythmic drugs].
Iturralde Torres P
Arch Cardiol Mex; 2007; 77 Suppl 4():S4-129-32. PubMed ID: 18938711
[TBL] [Abstract][Full Text] [Related]
34. Tissue omega-6/omega-3 fatty acid ratio and risk for coronary artery disease.
Harris WS; Assaad B; Poston WC
Am J Cardiol; 2006 Aug; 98(4A):19i-26i. PubMed ID: 16919513
[TBL] [Abstract][Full Text] [Related]
35. [Nutrition and health--fish fatty acids against fatal coronary heart disease].
Zock PL; Kromhout D
Ned Tijdschr Geneeskd; 2002 Nov; 146(47):2229-33. PubMed ID: 12481519
[TBL] [Abstract][Full Text] [Related]
36. Impact of optimal medical therapy with or without percutaneous coronary intervention on long-term cardiovascular end points in patients with stable coronary artery disease (from the COURAGE Trial).
Boden WE; O'Rourke RA; Teo KK; Maron DJ; Hartigan PM; Sedlis SP; Dada M; Labedi M; Spertus JA; Kostuk WJ; Berman DS; Shaw LJ; Chaitman BR; Mancini GB; Weintraub WS;
Am J Cardiol; 2009 Jul; 104(1):1-4. PubMed ID: 19576311
[TBL] [Abstract][Full Text] [Related]
37. Effect of omega-3 fatty acid supplementation on the arachidonic acid:eicosapentaenoic acid ratio.
Burns T; Maciejewski SR; Hamilton WR; Zheng M; Mooss AN; Hilleman DE
Pharmacotherapy; 2007 May; 27(5):633-8. PubMed ID: 17461697
[TBL] [Abstract][Full Text] [Related]
38. The cardiovascular effects of fish oils and omega-3 fatty acids.
Segal-Isaacson CJ; Wylie-Rosett J
Heart Dis; 1999; 1(3):149-54. PubMed ID: 11720618
[TBL] [Abstract][Full Text] [Related]
39. Preventing sudden death with n-3 (omega-3) fatty acids and defibrillators.
Kottke TE; Wu LA; Brekke LN; Brekke MJ; White RD
Am J Prev Med; 2006 Oct; 31(4):316-323. PubMed ID: 16979456
[TBL] [Abstract][Full Text] [Related]
40. N-3 fatty acids as secondary prevention against cardiovascular events in patients who undergo chronic hemodialysis: a randomized, placebo-controlled intervention trial.
Svensson M; Schmidt EB; Jørgensen KA; Christensen JH;
Clin J Am Soc Nephrol; 2006 Jul; 1(4):780-6. PubMed ID: 17699287
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
